Estrogen receptor-α signaling in post-natal mammary development and breast cancers | SpringerLink
Contribution of ER and NF-κB to endocrine resistance in inflammatory breast cancer | Breast Cancer Management
IJMS | Free Full-Text | Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer
An overview on Estrogen receptors signaling and its ligands in breast cancer - ScienceDirect
Selective estrogen receptor modulators contribute to prostate cancer treatment by regulating the tumor immune microenvironment | Journal for ImmunoTherapy of Cancer
Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance - ScienceDirect
Fulvestrant (ICI-182780) | ≥99%(HPLC) | Selleck | Estrogen/progestogen Receptor antagonist
Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase | PLOS ONE
Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
Crosstalk between Estrogen Signaling and Breast Cancer Metabolism: Trends in Endocrinology & Metabolism
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library
Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of Medicinal Chemistry
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)
Cells | Free Full-Text | Estrogen-Receptor Expression and Function in Female Reproductive Disease
Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review)
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Fulvestrant | CAS:129453-61-8 | Estrogen receptor antagonist,high affinity | High Purity | Manufacturer BioCrick
IJMS | Free Full-Text | Emerging Roles of Estrogen-Regulated Enhancer and Long Non-Coding RNAs
Targeting Androgen/Estrogen Receptors Crosstalk in Cancer: Trends in Cancer
Frontiers | Involvement of the Estrogen and Progesterone Axis in Cancer Stemness: Elucidating Molecular Mechanisms and Clinical Significance
The interaction between ER and NFκB in resistance to endocrine therapy | Breast Cancer Research | Full Text
